PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cellular and Molecular Research Center, Iran university of medical sciences, Tehran, Iran.\', \'School of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.\', \'Department of Neurology, Iran University of Medical Sciences, Tehran, Iran.\', \'School of Medicine, Shahid Beheshti Medical University, Tehran, Iran.\', \'Department of Neurosurgery, Iran University of Medical Sciences, Tehran, Iran.\', \'Department of Neurology, Iran University of Medical Sciences, Tehran, Iran. Zahra.Mirzaasgari@gmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s12883-021-02218-4
?:doi
?:hasPublicationType
?:journal
  • BMC neurology
is ?:pmid of
?:pmid
?:pmid
  • 33933026
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.006
?:rankingScore_hIndex
  • 59
is ?:relation_isRelatedTo_publication of
?:title
  • Rituximab and risk of COVID-19 infection and its severity in patients with MS and NMOSD.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33933026>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33933026>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all